戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 r who met the Amsterdam criteria for risk of hereditary nonpolyposis colorectal cancer.
2  mimic germline mutations observed for human hereditary nonpolyposis colorectal cancer.
3  hMLH1, hPMS1, and hPMS2 are associated with hereditary nonpolyposis colorectal cancer.
4  tumor testing indicate definite or probable hereditary nonpolyposis colorectal cancer.
5 e MSH2 allele frequency in Lynch syndrome or hereditary nonpolyposis colorectal cancer.
6 in the PMS2 gene are rare in the etiology of hereditary nonpolyposis colorectal cancer.
7 hat defects in MMR predispose individuals to hereditary nonpolyposis colorectal cancer.
8 mmon causes of hereditary diseases including hereditary nonpolyposis colorectal cancer.
9 y three had family histories consistent with hereditary nonpolyposis colorectal cancer.
10 y modify the age at onset of colon cancer in hereditary nonpolyposis colorectal cancer.
11 gene family underlie the MMP, a landmark for hereditary nonpolyposis colorectal cancer.
12 isk for cancer in carriers of a mutation for hereditary nonpolyposis colorectal cancer.
13  many hereditary cancer syndromes, including hereditary nonpolyposis colorectal cancer.
14 ons in human mismatch repair genes result in hereditary nonpolyposis colorectal cancers.
15 s, such as familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer, account for <
16 se the genetic instability characteristic of hereditary nonpolyposis colorectal cancer and a subset o
17 ating the underlying defects responsible for hereditary nonpolyposis colorectal cancer and familial a
18 ysis of two human familial cancer syndromes, hereditary nonpolyposis colorectal cancer and familial a
19 stability (MSI) in tumors from patients with hereditary nonpolyposis colorectal cancer and in a large
20 ch repair (MMR) is found in some hereditary (hereditary nonpolyposis colorectal cancer) and sporadic
21 ents did not meet any published criteria for hereditary nonpolyposis colorectal cancer, and six of th
22 ismatch repair gene MSH2 are associated with hereditary nonpolyposis colorectal cancer as well as a s
23 n human MutS genes cause a predisposition to hereditary nonpolyposis colorectal cancer as well as spo
24 uman cancer susceptibility syndrome known as hereditary nonpolyposis colorectal cancer, as well as so
25  maps to 2p15-2p16.1, a region implicated in hereditary nonpolyposis colorectal cancer, Carney comple
26                               In contrast to hereditary nonpolyposis colorectal cancer, characterized
27 ad to the development of the Lynch syndrome (hereditary nonpolyposis colorectal cancer), conferring a
28                  The majority of tumors from hereditary nonpolyposis colorectal cancer families and a
29 l phenotype of Lynch syndrome (also known as hereditary nonpolyposis colorectal cancer) has been well
30 tch repair (MMR) deficiency, which underlies hereditary nonpolyposis colorectal cancer, has recently
31               Women with the Lynch syndrome (hereditary nonpolyposis colorectal cancer) have a 40 to
32 nked to hMSH2 and also fits the criteria for hereditary nonpolyposis colorectal cancer, having early
33  incidence of rectal cancer in patients with hereditary nonpolyposis colorectal cancer (HNPCC) after
34 aving microsatellite instability, as seen in hereditary nonpolyposis colorectal cancer (HNPCC) and in
35          In the wake of the discoveries that hereditary nonpolyposis colorectal cancer (HNPCC) and ot
36  inherent in mismatch repair (MMR)-deficient hereditary nonpolyposis colorectal cancer (HNPCC) cells.
37                    Tumors from patients with hereditary nonpolyposis colorectal cancer (HNPCC) demons
38 ill Amsterdam criteria for Lynch syndrome or hereditary nonpolyposis colorectal cancer (HNPCC) do not
39 and MLH1 are responsible for the majority of hereditary nonpolyposis colorectal cancer (HNPCC) famili
40    The optimal strategy for the detection of hereditary nonpolyposis colorectal cancer (HNPCC) gene c
41            This study examines the impact of hereditary nonpolyposis colorectal cancer (HNPCC) geneti
42                           Recent advances in hereditary nonpolyposis colorectal cancer (HNPCC) have b
43 ensus guidelines for universal screening for hereditary nonpolyposis colorectal cancer (HNPCC) in pat
44                                              Hereditary Nonpolyposis Colorectal Cancer (HNPCC) is a g
45                                              Hereditary nonpolyposis colorectal cancer (HNPCC) is an
46                                              Hereditary nonpolyposis colorectal cancer (HNPCC) is an
47                                              Hereditary nonpolyposis colorectal cancer (HNPCC) is an
48                                              Hereditary nonpolyposis colorectal cancer (HNPCC) is ass
49                                              Hereditary nonpolyposis colorectal cancer (HNPCC) is cau
50           The autosomal dominant syndrome of Hereditary Nonpolyposis Colorectal Cancer (HNPCC) is due
51 due to hereditary cancer syndromes, of which hereditary nonpolyposis colorectal cancer (HNPCC) is the
52                                              Hereditary nonpolyposis colorectal cancer (HNPCC) is the
53 tations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer (HNPCC) kindre
54 luding familial adenomatous polyposis (FAP), hereditary nonpolyposis colorectal cancer (HNPCC) or Lyn
55 mismatch repair (MMR) gene mutation-negative hereditary nonpolyposis colorectal cancer (HNPCC) patien
56                               In a series of hereditary nonpolyposis colorectal cancer (HNPCC) patien
57  the colorectal cancer phenotype in multiple hereditary nonpolyposis colorectal cancer (HNPCC) pedigr
58 Mutations in the mismatch repair genes cause hereditary nonpolyposis colorectal cancer (HNPCC) syndro
59  Colorectal cancers arising in patients with hereditary nonpolyposis colorectal cancer (HNPCC) were e
60                                              Hereditary nonpolyposis colorectal cancer (HNPCC), also
61 on cancer predisposition syndrome in humans, hereditary nonpolyposis colorectal cancer (HNPCC), and a
62  disorder Lynch syndrome (LS), also known as hereditary nonpolyposis colorectal cancer (HNPCC), as we
63 m in colorectal neoplasms from patients with hereditary nonpolyposis colorectal cancer (HNPCC), famil
64  several genetic disorders, including Type I hereditary nonpolyposis colorectal cancer (HNPCC), famil
65 n cases, and the other in autosomal dominant hereditary nonpolyposis colorectal cancer (HNPCC), in wh
66 or hMLH1 mismatch repair gene results in the hereditary nonpolyposis colorectal cancer (HNPCC), or Ly
67 raction with Msh2 and Mlh1, genes that cause hereditary nonpolyposis colorectal cancer (HNPCC), we in
68 e human MutL homolog MLH1 from patients with hereditary nonpolyposis colorectal cancer (HNPCC).
69 ing in Ashkenazi Jewish patients at risk for Hereditary Nonpolyposis Colorectal Cancer (HNPCC).
70  be altered in the germline of patients with hereditary nonpolyposis colorectal cancer (HNPCC).
71 are familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC).
72 ations in DNA mismatch repair (MMR) genes or hereditary nonpolyposis colorectal cancer (HNPCC).
73  and the most frequent extracolonic tumor in hereditary nonpolyposis colorectal cancer (HNPCC).
74  colorectal carcinomas from individuals with hereditary nonpolyposis colorectal cancer (HNPCC).
75 ion of mismatch repair (MMR) genes underlies hereditary nonpolyposis colorectal cancer (HNPCC).
76 1 lead to the cancer susceptibility syndrome hereditary nonpolyposis colorectal cancer (HNPCC).
77 of the common cancer susceptibility syndrome hereditary nonpolyposis colorectal cancer (HNPCC).
78 nes that are involved in the pathogenesis of hereditary nonpolyposis colorectal cancer (HNPCC).
79 in hMSH2 have been found to cosegregate with hereditary nonpolyposis colorectal cancer (HNPCC).
80 ellite instability (MI), a characteristic of hereditary nonpolyposis colorectal cancers (HNPCC) and a
81                              Lynch syndrome (hereditary nonpolyposis colorectal cancer; HNPCC) is an
82 the Bethesda guidelines for the diagnosis of hereditary nonpolyposis colorectal cancer (including the
83 r proteins are known to cause instability in hereditary nonpolyposis colorectal cancer, instability t
84                                              Hereditary nonpolyposis colorectal cancer is a cancer su
85                                              Hereditary nonpolyposis colorectal cancer is associated
86                                              Hereditary nonpolyposis colorectal cancer is caused by g
87                                              Hereditary nonpolyposis colorectal cancer is caused by i
88 risk for cancer in carriers of mutations for hereditary nonpolyposis colorectal cancer is unclear.
89 ies at high risk for the Lynch syndrome (ie, hereditary nonpolyposis colorectal cancer) is critical f
90  syndromes: familial adenomatosus polyposis, hereditary nonpolyposis colorectal cancer, juvenile poly
91 ) using the panel of markers recommended for hereditary nonpolyposis colorectal cancer kindred and a
92 for tumor development in about half of known hereditary nonpolyposis colorectal cancer kindreds and a
93 ter age of onset and a lower penetrance than hereditary nonpolyposis colorectal cancer kindreds.
94  mutations of MMR genes in the patients with hereditary nonpolyposis colorectal cancer lead to inacti
95 lts clarify the position of the chromosome 2 hereditary nonpolyposis colorectal cancer locus, which w
96 h repair (MMR) gene MLH1 are associated with hereditary nonpolyposis colorectal cancer (Lynch syndrom
97 vide a molecular framework for understanding hereditary nonpolyposis colorectal cancer mutations and
98  cancer is associated most commonly with the hereditary nonpolyposis colorectal cancer or familial ad
99  the Knudson principle, PMS2 mutations cause hereditary nonpolyposis colorectal cancer or Turcot synd
100 ual absence of clinical premonitory signs in hereditary nonpolyposis colorectal cancer (or Lynch synd
101            MSI was detected in 16% using the hereditary nonpolyposis colorectal cancer panel and 22%
102 cted novel mutations in MLH1 in each of four hereditary nonpolyposis colorectal cancer patients.
103 omes include familial adenomatous polyposis, hereditary nonpolyposis colorectal cancer, Peutz-Jeghers
104                                     Clearly, hereditary nonpolyposis colorectal cancer provides an ex
105  been described in tumors from patients with hereditary nonpolyposis colorectal cancer, sporadic colo
106  commonly seen in tumors associated with the hereditary nonpolyposis colorectal cancer syndrome and i
107                                  Thirty-nine hereditary nonpolyposis colorectal cancer syndrome carci
108 as a screening criterion for Lynch syndrome (hereditary nonpolyposis colorectal cancer syndrome).
109 llite instability (MSI-H) is the hallmark of hereditary nonpolyposis colorectal cancer syndrome, and
110 common type of extracolonic neoplasia in the hereditary nonpolyposis colorectal cancer syndrome, but
111 h as the hereditary breast cancer syndromes, hereditary nonpolyposis colorectal cancer syndrome, Peut
112  increased cancer risk characteristic of the hereditary nonpolyposis colorectal cancer syndrome.
113 ous study demonstrated that in families with hereditary nonpolyposis colorectal cancer, the age of on
114  disease, familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer, together acco
115                   Carriers of a mutation for hereditary nonpolyposis colorectal cancer who were 25 ye
116 fe expectancy for carriers of a mutation for hereditary nonpolyposis colorectal cancer, with benefits

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top